Skip to content

A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02026102
Enrollment
15
Registered
2014-01-01
Start date
2014-09-30
Completion date
2016-11-30
Last updated
2019-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Cardiac Death, Systolic Heart Failure

Keywords

decision aid, patient decision making, heart failure, ejection fraction, primary prevention, implantable cardioverter defibrillator, ICD, pilot trial, patient centered health care

Brief summary

The purpose of this study is to test the acceptability and feasibility of a toolkit of patient decision aids (PtDAs) for heart failure patients who are considering an ICD implant.

Detailed description

Specific Aim 1: Examine acceptability and feasibility of a toolkit of patient decision aids (PtDAs) for patients with heart failure referred for primary prevention implantable cardioverter-defibrillators using a randomized control trial design across three diverse health care systems (Kaiser Colorado, The University of Colorado, and The Denver Veterans Hospital). 1. Measure the acceptability of the decision aids 2. Explore feasibility by measuring patient participation rates and adherence to the study protocol across all three sites. 3. Conduct a preliminary assessment of outcomes by measuring changes in decision quality (knowledge and value concordance), quality of life, depressive symptoms, health status, and spiritual well-being. Specific Aim 2: Determine the relative value of the various tools in the toolkit through in-depth interviews from study participants and providers at each intervention site

Interventions

BEHAVIORALICD Decision Aid Toolkit

Research assistants will provide patients with a toolkit of decision aids. Participants will have the option of using all of the decision aids or just some of the decision aids.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* systolic heart failure (defined as an ejection fraction less than 35%) * have been referred for a primary prevention ICD * Note: Patients referred for an ICD with cardiac resynchronization therapy are NOT excluded.

Exclusion criteria

* Already have an ICD * Non-English speaking (as the tools we have developed are only available in English currently) * Other ICD indications (e.g. secondary prevention, hypertrophic obstructive cardiomyopathy) * Cognitive Impairment defined only as people with an inability to consent

Design outcomes

Primary

MeasureTime frameDescription
Measure the acceptability and feasibility of the decision aidspre-ICD discussion - baselineAcceptability-measure decision aid acceptability using modified version of decision aid acceptability developed by Barry et al. Feasibility-explore participation rates and adherence to study protocol; weekly team meetings to discuss recruitment strategies Knowledge: 21 item knowledge measure developed in-house Decision Conflict: validated 15-item decision conflict measure developed by O'Connor et al. Decision Regret: validated 5-item decision regret scale Decision choice: ultimate choice patient made about getting an ICD Decision participation: Prior to intervention, we measure patients' preferred role in decision making using the control preferences scale. After the decision, we measure the participants' actual role in decision making. Anxiety and Depression: Hospital Anxiety and Depression Scale (HADS). Chart Review Outcome: For those that had not yet had a procedure, we will review the charts at the end of study to determine if they received an ICD or not.

Secondary

MeasureTime frameDescription
Determine relative value of the four decision aids3 months after baseline interviewDetermine the relative value of the various tools in the toolkit through in-depth interviews from study participants and providers at each intervention site. We will ask participants the following questions: * Have you made a decision about getting or not getting the ICD? * What information did you use to make your decision? * How are you feeling about your decision? * What else would have been helpful in making your decision? * (Intervention only) Did you use any of the decision aids you were given? * If yes, please tell us how you used them? Did the decision aids make you feel better or worse about your decision? Did you like one of them better than the others? Is there any aspect that wasn't helpful? * If no, please tell us why not? What would have been helpful? * Do you have any advice on the best way to deliver these decision aids to future patients?
Measure the acceptability and feasibility of the decision aidswithin 4 weeks of meeting with electrophysiologistAcceptability-measure decision aid acceptability using modified version of decision aid acceptability developed by Barry et al. Feasibility-explore participation rates and adherence to study protocol; weekly team meetings to discuss recruitment strategies Knowledge: 21 item knowledge measure developed in-house Decision Conflict: validated 15-item decision conflict measure developed by O'Connor et al. Decision Regret: validated 5-item decision regret scale Decision choice: ultimate choice patient made about getting an ICD Decision participation: Prior to intervention, we measure patients' preferred role in decision making using the control preferences scale. After the decision, we measure the participants' actual role in decision making. Anxiety and Depression: Hospital Anxiety and Depression Scale (HADS). Chart Review Outcome: For those that had not yet had a procedure, we will review the charts at the end of study to determine if they received an ICD or not.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026